NGNE
Neurogene Inc.
NASDAQ · USHealthcareBiotechnology
$37.34+0.08%
Price as of Jul 20, 2026
NGNE analysis
Neurogene Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for NGNE is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research